 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||||| 6MW3511 / Mabwell (Shanghai) Biosci
New P1/2 trial, Metastases: 6MW3511 in Patients With Advanced Solid Tumor (clinicaltrials.gov) - Sep 1, 2022
P1/2, N=272, Not yet recruiting, Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.